financetom
Business
financetom
/
Business
/
India's largest kitchenware maker plans to export more as local demand is still sluggish
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
India's largest kitchenware maker plans to export more as local demand is still sluggish
Mar 31, 2023 4:11 AM

India's largest kitchenware maker, TTK Prestige were witnessing a mild slowdown in consumer demand. In an interaction with CNBC-TV18 on February 24, TT Jagannathan, Chairman of the company admitted that the domestic market, particularly rural, has slowed down. In response, the company is looking to shift some of its volumes to exports where demand is stronger.

Share Market Live

NSE

Jagannathan noted that export demand is getting stronger and is set to contribute significantly to the company's revenue in the upcoming fiscal year.

He revealed that export currently accounts for 5 percent of the company's revenue, but this is set to double in FY24, where it will contribute 10 percent.

“Additional growth will come only from export and expert growth will double next year,” he said.

Moreover, Jagannathan stated that the export margin is between 10-15 percent which is quite impressive. However, he noted that the domestic business margin is even better, ranging between 15-18 percent.

“It depends on customer-to-customer, export margins are between 10-15 percent and domestic margins will be between 15-18 percent,” he said.

Read Here | Morgan Stanley upgrades India to equalweight on narrowing valuation premium

Nevertheless, with the projected increase in export demand, the company's overall revenue is expected to see double-digit growth for FY24.

Overall, the demand situation for TTK Prestige is better than the last two quarters, with export growth set to play a significant role in the company's revenue growth.

Jagannathan predicts that the EBITDA margin will be in the range of 15-17 percent indicating healthy profitability for the company.

The Chairman also provided insights into the company's production capacity, assuring that they have enough product capacity to last them 5 years in the domestic market.

Moreover, the FY24 capex is estimated to be around Rs 75-80 crore, which indicates the company's commitment to continued growth and expansion.

Read Here | India signs Rs 19,600-crore contracts to buy 11 patrol, 6 missile vessels

(Edited by : Abhishek Jha)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved